3.375g Piperacillin and Tazobactam for Injection in 0.3% Sodium Chloride for Injection in 50mL DUPLEX Container - 24/Case (3448-11)

MSRP: $949.95
$685.00
(You save $264.95 )
(No reviews yet) Write a Review
SKU:
PST-BBR-3448-11
  • Used as a combination penicillin-class antibacterial and beta-lactamase inhibitor for treating various bacterial infections

Uses

  • Intra-abdominal Infections: 
    • Specifically appendicitis (complicated by rupture or abscess) and peritonitis
  • Pneumonia: 
    • Indicated for nosocomial (hospital-acquired) and community-acquired pneumonia of moderate-to-severe severity
  • Skin and Skin Structure Infections: 
    • Used for cellulitis, cutaneous abscesses, and ischemic/diabetic foot infections
  • Female Pelvic Infections: 
    • Including postpartum endometritis and pelvic inflammatory disease

Features

  • DUPLEX® Drug Delivery System: 
    • A dual-chamber, flexible IV bag that stores the drug (powder) and diluent (0.3% Sodium Chloride) separately until activation
  • Ready-to-Activate: 
    • Requires no manual mixing, thawing, or special equipment; it is activated at the patient's bedside by folding and squeezing the bag
  • Dosing Accuracy: 
    • Pre-filled with an exact dose of 3.375g (3g piperacillin and 0.375g tazobactam) and 50mL of diluent
  • Integrated Safety: 
    • The container is not made with PVC, DEHP, or natural rubber latex and features a barcode that identifies the final mixed drug to ensure administration accuracy
  • Convenient Storage: 
    • Can be stored at room temperature, saving pharmacy space compared to frozen or refrigerated options

Benefits

  • Reduces Medication Errors: 
    • By eliminating manual compounding and complex reconstitution steps, it significantly lowers the risk of calculation or mixing errors
  • Improved Efficiency: 
    • Reduces nursing labor time by up to 35% compared to other systems and has a faster reconstitution time than traditional compounding
  • Enhanced Infection Control: 
    • The closed system prevents contamination during preparation and protects healthcare workers from exposure to airborne drug particles
  • Regulatory Compliance: 
    • Designed to meet USP <797> guidelines for sterile compounding and The Joint Commission safety standards

Contents

  • 3.375g Piperacillin and Tazobactam for Injection in 0.3% Sodium Chloride for Injection in 50mL DUPLEX Container
  • 24 Containers per case